DRI and DRIF helping to find a cure for Type 1 Diabetes


Funds raised support the Diabetes Research Institute (DRI), a recognized world leader in cure-focused research. Pioneering many of the techniques used in islet cell transplantation since the early 1970’s, the DRI has successfully reversed diabetes in patients involved in ongoing clinical trials. The Institute’s research is now directed at improving transplant processes and developing new biomedical technologies and cell-based therapies to restore insulin production.

To build upon and accelerate the progress toward a cure, the Institute continually develops international research partnerships while serving as a global resource and training center for investigators working in islet cell research. Our new global federation of diabetes centers in Edmonton, Barcelona, Milan, Palermo, Stockholm, Kyoto, and now 6 centers in Israel, have created a unique opportunity for us to accelerate our research tremendously.

The most comprehensive diabetes research facility of its kind, the DRI conducts a broad range of scientific programs in the rapidly evolving fields of pancreatic stem cell development, transplant immunology, molecular biology, genetic engineering and regenerative medicine, among others, to speed the most promising findings from the lab to the patient.

Within its own community, the DRI is a Center of Excellence at the University of Miami Leonard M. Miller School of Medicine, and serves as the State of Florida’s Regional Diabetes Center, providing the latest in patient and professional education, ensuring the highest standards of health care delivery.

Our Mission

To develop and rapidly apply the most promising research to treat and cure those now living with diabetes.


Learn more about the Diabetes Research Institute by clicking here.